Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Alexia Letierce

1PUBLICATIONS

18CO-AUTHORS

Carbon capture engineering (excl. sequestration)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 20, 2025

Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Adolescents With Cystic Fibrosis.

Alfonso Galderisi, Laurence Weiss, Alix Besançon

Pageof 1

Frequent Collaborators

1 joint publications

Alfonso Galderisi

1 joint publications

Laurence Weiss

1 joint publications

Nathalie Stremler

1 joint publications

Philippe Reix

1 joint publications

Caroline Perisson

1 joint publications

Marie-Laure Dalphin

1 joint publications

Véronique Houdouin

1 joint publications

Katia Bessaci

1 joint publications

Laure Cosson

1 joint publications

Asma Gabsi

Frequent Collaborators

1 joint publications

Alfonso Galderisi

1 joint publications

Laurence Weiss

1 joint publications

Nathalie Stremler

1 joint publications

Philippe Reix

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

See more related videos